Brief: ChromaDex Secures US Patent for the Composition of Matter of Salt Forms of NMNH
Aug 19 (Reuters) - Chromadex Corp CDXC.O :
* CHROMADEX SECURES U.S. PATENT FOR THE COMPOSITION OF
MATTER OF
SALT FORMS OF NMNH (DIHYDRONICOTINAMIDE MONONUCLEOTIDE), A
PRECURSOR TO NAD+
* CHROMADEX - CONTINUOUSLY EVALUATES & INVESTIGATES
NEXT-GENERATION NAD+ PRECURSORS AT FOREFRONT OF BURGEONING
HEALTHY AGING CATEGORY
Source text for Eikon: ID:nBw4cHQx6a
Further company coverage: CDXC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Niagen Bioscience
See all newsAs weight-loss drug users turn to dietary supplements, doctors, regulators raise flags
Niagen Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Niagen Bioscience Q2 net sales fall, missing estimates
Niagen Bioscience Inc expected to post earnings of 2 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Salesforce